SHUXING ZHANG to Cell Line, Tumor
This is a "connection" page, showing publications SHUXING ZHANG has written about Cell Line, Tumor.
Connection Strength
0.041
-
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein. Cancer Res. 2014 Jun 01; 74(11):3127-36.
Score: 0.010
-
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39.
Score: 0.008
-
3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in I?Ba kinase, leading to down-regulation of nuclear factor-?B (NF-?B)-regulated gene products and sensitization of tumor cells. J Biol Chem. 2012 Jan 02; 287(1):245-256.
Score: 0.008
-
Development of sulfonamide AKT PH domain inhibitors. Bioorg Med Chem. 2011 Mar 15; 19(6):2046-54.
Score: 0.008
-
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. Cancer Res. 2009 Jun 15; 69(12):5073-81.
Score: 0.007